NASDAQ · Healthcare · Biotechnology
Hemab Therapeutics Holdings, Inc. Common Stock
COAG
Hemab Therapeutics Holdings, Inc. CEO Benny Sorensen · Market cap $65.0M.
$32.37
+4.65 · +16.77%
52w hi $36.6152w lo $23.00
Off 52w high 27.8%
76
STRONG
Current InsiderScore
Corp · 90d
15
15 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
5
1 strong · 4 notable
Analyst consensus
—
Avg PT $41.40
Section 01
Recent Form 4 filings
15 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 16 | RA CAPITAL MANAGEMENT, L.P. | Buy | 61,523 | $24.98 | +$1.54M | 60 | |
| Jun 15 | RA CAPITAL MANAGEMENT, L.P. | Buy | 6,146 | $24.89 | +$153K | 54 | |
| May 19 | RA CAPITAL MANAGEMENT, L.P. | Buy | 3,802 | $24.97 | +$95K | 37 | |
| May 12 | RA CAPITAL MANAGEMENT, L.P. | Buy | 6,387 | $24.90 | +$159K | 46 | |
| May 11 | RA CAPITAL MANAGEMENT, L.P. | Buy | 25,720 | $25.00 | +$643K | 57 | |
| May 11 | RA CAPITAL MANAGEMENT, L.P. | Buy | 14,149 | $24.47 | +$346K | 54 | |
| May 08 | RA CAPITAL MANAGEMENT, L.P. | Buy | 1,483 | $24.98 | +$37K | 35 | |
| May 07 | RA CAPITAL MANAGEMENT, L.P. | Buy | 1,985 | $24.95 | +$50K | 35 | |
| May 07 | RA CAPITAL MANAGEMENT, L.P. | Buy | 7,921 | $24.34 | +$193K | 54 | |
| May 06 | RA CAPITAL MANAGEMENT, L.P. | Buy | 14,611 | $23.77 | +$347K | 54 | |
| May 06 | RA CAPITAL MANAGEMENT, L.P. | Buy | 53,407 | $24.83 | +$1.33M | 60 | |
| May 05 | RA CAPITAL MANAGEMENT, L.P. | Buy | 10,268 | $25.00 | +$257K | 54 | |
| May 05 | RA CAPITAL MANAGEMENT, L.P. | Buy | 87,143 | $24.59 | +$2.14M | 60 | |
| May 04 | RA CAPITAL MANAGEMENT, L.P. | Buy | 133,750 | $18.00 | +$2.41M | 73 | |
| May 04 | RA CAPITAL MANAGEMENT, L.P. | Buy | 2,541,250 | $18.00 | +$45.74M | 76 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun